CVE-2019-13543: CWE-798 Use of Hard-coded Credentials in Medtronic Valleylab Exchange Client
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use multiple sets of hard-coded credentials. If discovered, they can be used to read files on the device.
AI Analysis
Technical Summary
CVE-2019-13543 is a medium-severity vulnerability identified in Medtronic's Valleylab Exchange Client and related energy platform software versions. Specifically, the affected products include Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below. The vulnerability arises from the use of multiple sets of hard-coded credentials embedded within the software. These credentials are static and cannot be changed by the end user or administrator. An attacker who discovers these hard-coded credentials can leverage them to gain unauthorized read access to files on the affected devices. The vulnerability does not require any authentication or user interaction to exploit, and it can be exploited remotely over the network (as indicated by the CVSS vector AV:N/AC:L/PR:N/UI:N). The scope is classified as changed (S:C) because the vulnerability affects components beyond the initially vulnerable software, potentially impacting confidentiality across interconnected systems. The impact is limited to confidentiality, with no direct effect on integrity or availability. The CVSS v3.1 base score is 5.8, reflecting a medium severity level. No known exploits in the wild have been reported to date, and no official patches or mitigation links are provided by the vendor. The root cause is classified under CWE-798, which refers to the use of hard-coded credentials, a common security anti-pattern that can lead to unauthorized access if discovered. Given the nature of the affected products—medical energy platforms and exchange clients used in clinical environments—this vulnerability could expose sensitive medical device data or operational information, potentially compromising patient privacy or clinical workflows if exploited.
Potential Impact
For European organizations, particularly healthcare providers and medical facilities using Medtronic's Valleylab products, this vulnerability poses a risk to the confidentiality of sensitive medical data stored or processed on these devices. Unauthorized access to device files could lead to exposure of patient information or proprietary clinical data. Although the vulnerability does not directly impact device availability or integrity, the confidentiality breach could undermine trust in medical device security and compliance with stringent European data protection regulations such as GDPR. Additionally, compromised devices might be used as footholds for lateral movement within hospital networks, increasing the risk of broader network intrusion. The lack of authentication and user interaction requirements makes this vulnerability easier to exploit remotely, raising concerns for network-exposed devices. Given the critical role of these devices in clinical settings, any security incident could disrupt medical workflows and patient care indirectly, even if the device functionality remains intact.
Mitigation Recommendations
Since no official patches are available, European healthcare organizations should implement compensating controls to mitigate this vulnerability. First, network segmentation should be enforced to isolate affected devices from general hospital networks and restrict access to trusted personnel and systems only. Deploy strict firewall rules and access control lists (ACLs) to limit inbound and outbound traffic to and from these devices. Conduct thorough inventory and asset management to identify all instances of the affected Medtronic products and assess their exposure. Employ network monitoring and intrusion detection systems (IDS) to detect anomalous access attempts or suspicious activities targeting these devices. Where possible, replace or upgrade to newer versions of the software or hardware that do not contain hard-coded credentials. If device replacement is not feasible, consider additional endpoint security controls such as application whitelisting and enhanced logging to detect unauthorized access. Finally, ensure that all staff are trained on the risks associated with these devices and the importance of maintaining strict physical and network security controls around medical equipment.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, Sweden, Switzerland, Austria
CVE-2019-13543: CWE-798 Use of Hard-coded Credentials in Medtronic Valleylab Exchange Client
Description
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use multiple sets of hard-coded credentials. If discovered, they can be used to read files on the device.
AI-Powered Analysis
Technical Analysis
CVE-2019-13543 is a medium-severity vulnerability identified in Medtronic's Valleylab Exchange Client and related energy platform software versions. Specifically, the affected products include Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below. The vulnerability arises from the use of multiple sets of hard-coded credentials embedded within the software. These credentials are static and cannot be changed by the end user or administrator. An attacker who discovers these hard-coded credentials can leverage them to gain unauthorized read access to files on the affected devices. The vulnerability does not require any authentication or user interaction to exploit, and it can be exploited remotely over the network (as indicated by the CVSS vector AV:N/AC:L/PR:N/UI:N). The scope is classified as changed (S:C) because the vulnerability affects components beyond the initially vulnerable software, potentially impacting confidentiality across interconnected systems. The impact is limited to confidentiality, with no direct effect on integrity or availability. The CVSS v3.1 base score is 5.8, reflecting a medium severity level. No known exploits in the wild have been reported to date, and no official patches or mitigation links are provided by the vendor. The root cause is classified under CWE-798, which refers to the use of hard-coded credentials, a common security anti-pattern that can lead to unauthorized access if discovered. Given the nature of the affected products—medical energy platforms and exchange clients used in clinical environments—this vulnerability could expose sensitive medical device data or operational information, potentially compromising patient privacy or clinical workflows if exploited.
Potential Impact
For European organizations, particularly healthcare providers and medical facilities using Medtronic's Valleylab products, this vulnerability poses a risk to the confidentiality of sensitive medical data stored or processed on these devices. Unauthorized access to device files could lead to exposure of patient information or proprietary clinical data. Although the vulnerability does not directly impact device availability or integrity, the confidentiality breach could undermine trust in medical device security and compliance with stringent European data protection regulations such as GDPR. Additionally, compromised devices might be used as footholds for lateral movement within hospital networks, increasing the risk of broader network intrusion. The lack of authentication and user interaction requirements makes this vulnerability easier to exploit remotely, raising concerns for network-exposed devices. Given the critical role of these devices in clinical settings, any security incident could disrupt medical workflows and patient care indirectly, even if the device functionality remains intact.
Mitigation Recommendations
Since no official patches are available, European healthcare organizations should implement compensating controls to mitigate this vulnerability. First, network segmentation should be enforced to isolate affected devices from general hospital networks and restrict access to trusted personnel and systems only. Deploy strict firewall rules and access control lists (ACLs) to limit inbound and outbound traffic to and from these devices. Conduct thorough inventory and asset management to identify all instances of the affected Medtronic products and assess their exposure. Employ network monitoring and intrusion detection systems (IDS) to detect anomalous access attempts or suspicious activities targeting these devices. Where possible, replace or upgrade to newer versions of the software or hardware that do not contain hard-coded credentials. If device replacement is not feasible, consider additional endpoint security controls such as application whitelisting and enhanced logging to detect unauthorized access. Finally, ensure that all staff are trained on the risks associated with these devices and the importance of maintaining strict physical and network security controls around medical equipment.
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- icscert
- Date Reserved
- 2019-07-11T00:00:00
- Cisa Enriched
- false
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682f866a0acd01a249266e65
Added to database: 5/22/2025, 8:17:46 PM
Last enriched: 7/8/2025, 6:10:05 AM
Last updated: 2/3/2026, 1:56:16 PM
Views: 34
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Related Threats
CVE-2025-7760: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Ofisimo Web-Based Software Technologies Association Web Package Flora
HighCVE-2025-6397: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Ankara Hosting Website Design Website Software
HighHackers Leak 5.1 Million Panera Bread Records
MediumCVE-2026-1664: CWE-639 Authorization Bypass Through User-Controlled Key
MediumCVE-2025-11598: CWE-359 Exposure of Private Personal Information to an Unauthorized Actor in Centralny Ośrodek Informatyki mObywatel
LowActions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console in Console -> Billing for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.